Related Experiment Videos
Pemoline-induced Tourette's disorder: a case report
The American Journal of Psychiatry
|August 1, 1981
Summary
A 14-year-old boy developed Gilles de la Tourette's disorder during pemoline therapy. His tics persisted even after discontinuing the medication, differing from previous case reports.
Area of Science:
- Neuroscience
- Pharmacology
- Pediatric Neurology
Background:
- Pemoline is a stimulant medication historically used for conditions like ADHD.
- Gilles de la Tourette's disorder is a neurological condition characterized by involuntary movements and vocalizations (tics).
- Previous reports have suggested a link between pemoline and the development or exacerbation of tics.
Observation:
- A 14-year-old male patient was treated with pemoline.
- The patient subsequently developed symptoms consistent with Gilles de la Tourette's disorder.
- The tics observed in this case did not resolve after pemoline cessation.
Findings:
- This case highlights a persistent form of drug-induced Gilles de la Tourette's disorder.
- The patient's tic disorder was refractory to the withdrawal of pemoline.
- This presentation deviates from the typically expected remission in similar reported cases.
Implications:
- The findings suggest that pemoline-induced tics may sometimes be persistent and not easily reversible.
- Further research is needed to understand the long-term neurobiological effects of pemoline.
- Clinicians should be aware of the potential for persistent tic disorders following pemoline exposure in adolescents.